Predilife S.A (ALPRE) | Financial Analysis & Statements
Predilife S.A. Small-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Income Metrics
Balance Sheet Metrics
Total Assets
2.4M
Total Liabilities
6.7M
Shareholders Equity
-4.3M
Cash Flow Metrics
Revenue & Profitability Trend
Annual Income Flow
2024
Predilife S.A Income Statement From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 618.1K | 317.8K | 288.7K | 142.7K | 282.2K |
| Cost of Goods Sold | 13.8K | 10.9K | 36.2K | 49.3K | 38.6K |
| Gross Profit | 604.2K | 306.9K | 252.5K | 93.4K | 243.6K |
| Gross Margin % | 97.8% | 96.6% | 87.5% | 65.4% | 86.3% |
| Operating Expenses | |||||
| Research & Development | - | - | - | - | - |
| Selling, General & Administrative | - | - | - | 1.2M | 793.1K |
| Other Operating Expenses | 2.2M | 2.1M | 1.9M | 1.7M | 284.4K |
| Total Operating Expenses | 2.2M | 2.1M | 1.9M | 2.9M | 1.1M |
| Operating Income | -4.0M | -3.8M | -3.5M | -3.5M | -2.5M |
| Operating Margin % | -645.0% | -1,208.2% | -1,211.7% | -2,460.5% | -881.3% |
| Non-Operating Items | |||||
| Interest Income | 36.1K | 310 | 68 | - | - |
| Interest Expense | 858.4K | 616.9K | 300.7K | 188.8K | 44.0K |
| Other Non-Operating Income | - | - | - | - | - |
| Pre-tax Income | -4.8M | -4.5M | -3.8M | -3.7M | -2.5M |
| Income Tax | -342.4K | -232.1K | -256.1K | -294.8K | -290.3K |
| Effective Tax Rate % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Income | 198.6M | -4.2M | -3.6M | -3.4M | -2.3M |
| Net Margin % | 32,137.4% | -1,326.7% | -1,262.9% | -2,385.6% | -797.5% |
| Key Metrics | |||||
| EBITDA | -4.0M | -3.8M | -3.5M | -3.5M | -2.5M |
| EPS (Basic) | - | €-1.14 | €-1.00 | €-0.93 | €-0.64 |
| EPS (Diluted) | - | €-1.14 | €-1.00 | €-0.93 | €-0.64 |
| Basic Shares Outstanding | - | 3698843 | 3720277 | 3645723 | 3516550 |
| Diluted Shares Outstanding | - | 3698843 | 3720277 | 3645723 | 3516550 |
Income Statement Trend
Predilife S.A Balance Sheet From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 1.1M | 2.5M | 3.7M | 2.8M | 3.1M |
| Short-term Investments | - | 918.2K | 94.4K | 94.9K | 86.3K |
| Accounts Receivable | 430.4K | 176.6K | 134.0K | 107.6K | 31.1K |
| Inventory | - | - | - | 8.8K | - |
| Other Current Assets | - | -1 | -1 | 1 | 1 |
| Total Current Assets | 2.0M | 3.3M | 4.6M | 3.7M | 3.8M |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 18.7K | 18.7K | - | - | - |
| Goodwill | 0 | 21.2K | - | - | - |
| Intangible Assets | - | 21.2K | - | - | - |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | - | - | - | - | - |
| Total Non-Current Assets | 458.1K | 1.1M | 4.6M | 270.7K | 288.4K |
| Total Assets | 2.4M | 4.4M | 9.2M | 4.0M | 4.1M |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 420.2K | 336.3K | 249.7K | 179.0K | 208.5K |
| Short-term Debt | 493.7K | 428.4K | 52.4K | 351.4K | - |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | - | 249.9K | 383.3K | 20.7K | 221.9K |
| Total Current Liabilities | 1.7M | 710.1K | 1.2M | 400.3K | 637.7K |
| Non-Current Liabilities | |||||
| Long-term Debt | 4.5M | 7.4M | 7.0M | 5.1M | 2.7M |
| Deferred Tax Liabilities | - | - | - | - | - |
| Other Non-Current Liabilities | 564.3K | 169.8K | 2.0M | 1 | 221.9K |
| Total Non-Current Liabilities | 5.0M | 7.6M | 7.0M | 5.1M | 2.7M |
| Total Liabilities | 6.7M | 8.3M | 8.2M | 5.5M | 3.4M |
| Equity | |||||
| Common Stock | 94.1K | 93.0K | 91.5K | 91.5K | 87.3K |
| Retained Earnings | -4.3M | -4.2M | -13.9M | -3.4M | -2.3M |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | -4.3M | -3.9M | 957.0K | -1.6M | 721.7K |
| Key Metrics | |||||
| Total Debt | 4.9M | 7.9M | 7.1M | 5.5M | 2.7M |
| Working Capital | 291.8K | 2.6M | 3.4M | 3.3M | 3.2M |
Balance Sheet Composition
Predilife S.A Cash Flow Statement From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | -4.3M | -4.2M | -3.7M | -3.4M | -2.3M |
| Depreciation & Amortization | - | - | - | - | - |
| Stock-Based Compensation | - | - | - | - | - |
| Working Capital Changes | 0 | 0 | 0 | 0 | 0 |
| Operating Cash Flow | -4.3M | -4.2M | -3.7M | -3.4M | -2.3M |
| Investing Activities | |||||
| Capital Expenditures | -5.4K | -42.4K | 7.7K | -3.4K | -15.7K |
| Acquisitions | - | - | - | - | - |
| Investment Purchases | - | - | - | - | - |
| Investment Sales | - | - | - | - | - |
| Investing Cash Flow | -706.4K | -42.4K | 7.7K | -10.6K | -33.7K |
| Financing Activities | |||||
| Share Repurchases | - | -12.9K | -12.4K | -8.6K | - |
| Dividends Paid | - | - | - | - | - |
| Debt Issuance | 3.8M | 3.6M | 2.4M | 2.6M | 1.4M |
| Debt Repayment | -2.4M | -96.7K | -193.2K | -157.8K | -95.8K |
| Financing Cash Flow | 2.2M | 3.0M | 4.0M | 3.5M | 5.0M |
| Free Cash Flow | -3.7M | -4.3M | -3.1M | -3.8M | -2.1M |
| Net Change in Cash | -2.7M | -1.2M | 305.7K | 86.6K | 2.7M |
Cash Flow Trend
Predilife S.A Key Financial Ratios
Valuation Ratios
Forward P/E
-2.03
Price to Sales
16.78
Profitability Ratios
Profit Margin
97.76%
Operating Margin
-402.94%
Return on Equity
-4,653.75%
Return on Assets
-116.19%
Financial Health
Current Ratio
0.45
Debt to Equity
-1.15
Beta
0.27
Per Share Data
EPS (TTM)
€-1.06
Book Value per Share
€-4.00
Revenue per Share
€0.19
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| ALPRE | 12.2M | - | - | -4,653.75% | 97.76% | -1.15 |
| Eurofins Scientific | 10.8B | 24.24 | 3.08 | 9.50% | 6.51% | 96.84 |
| bioMérieux S.A | 8.4B | 21.24 | 2.04 | 9.54% | 9.77% | 11.24 |
| Eurofins Cerep SAS | 79.7M | 12.94 | - | 8.74% | 15.86% | 0.10 |
| Klea Holding | 54.0M | 17.58 | 1.98 | 9.14% | 11.89% | 18.40 |
| Lumibird S.A | 540.6M | 38.59 | 2.64 | 6.93% | 6.13% | 70.86 |
Financial data is updated regularly. All figures are in the company's reporting currency.